Arq. Bras. Cardiol. 2022; 119(3): 370-371

Anticoagulation Therapy with Warfarin: A Reality of Brazilian Public Health that Lacks Structure for Better Control

Martino Martinelli Filho ORCID logo

DOI: 10.36660/abc.20220504

This Short Editorial is referred by the Research article "Quality of Oral Anticoagulation in Atrial Fibrillation Patients at a Tertiary Hospital in Brazil".

The increase in longevity in recent decades has led to a progressive increase in the prevalence of atrial fibrillation (AF) worldwide. ,

As a result, anticoagulation therapy has become increasingly indicated in preventing thromboembolic events. The need for continuous use drove the preference for oral anticoagulants, historically represented by antivitamin K (VKA) drugs and, more recently, by new anticoagulants (anti-factor X). Among these, a VKA, warfarin, is the most prominent for its low cost.

[…]

Anticoagulation Therapy with Warfarin: A Reality of Brazilian Public Health that Lacks Structure for Better Control

Comments

Skip to content